Symmetry Technologies Inc. licenses a Human Rejuvenation Nutraceutical product from an FDA compliant laboratory. It will sell under the name "Resurgencell" in the yearly $200 billion USD Nutraceutical market
01 août 2013 16h00 HE
|
Symmetry Technologies Inc.
Houston,Tx, Aug. 1, 2013 (GLOBE NEWSWIRE) -- Symmetry Technologies Inc. (OTC:SMMR) is pleased to
announce that it has licensed a Human Rejuvenation Nutraceutical
product for retail sale from a US...